Plain-English translation of NCT03893188 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The SwissPrEPared Study is following people in Switzerland who are using PrEP (a daily medication that prevents HIV infection) to understand how many people are taking it, how well it's working, and whether they're experiencing any other sexually transmitted infections. Researchers want to learn more about the sexual health and well-being of people using this medication.
Little is known about how many people in Switzerland are using HIV prevention medication, or what health outcomes they experience while taking it. This study will help doctors and public health officials understand the real-world impact of this medication and identify any health concerns that need attention.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be asked to visit one of the participating clinics in Switzerland regularly. At these visits, you'll answer questionnaires about your sexual health and well-being, and the study team may test you for sexually transmitted infections. The study will track your health over time as you use the HIV prevention medication.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Switzerland